Pradaxa maker Boehringer Ingelheim Pharmaceuticals, Inc. plans to challenge a $1.25 million jury award on behalf of a woman who died from gastrointestinal bleeding after using the blood thinner.
The verdict for Betty Knight was the first plaintiff’s verdict in a Pradaxa suit, her attorneys said.
The jury in the U.S. District Court for the Southern District of West Virginia awarded $250,000 in compensatory damages and $1 million in punitive damages Oct. 18 to Knight’s family.
Knight suffered serious gastrointestinal bleeding in May 2013 after using Pradaxa for 18 months. She died in September 2013.
The jury found for the ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.